memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

dcYJ ,II:] ;Y X]X1 FEu@QE@$}(}h& JUllK,_0@J l~?Q~?8T d^Mi bx:6:bHx yp8h11 !vf,fp5fp An Q@? t-tt. KzWKtzWK@U z0Z@WxG B{Q6/{Q 11P4 \w1w$: {sT7yc E8 Zew *Bz u\ T3aHh:’J ~Bzvwwr% #[g%T( -qD-5-@c3U n\8whV NL1 [&6 OP!&OB!|O ,Y {%ZxzWc zh2igg z;h#|o;oo#ZR 4`e;{[4`s E9f\VKE jp/`[t0p~)0 MS&9SX7]WPX]MM @0A-k&G05VG l~l2ICl` p&##/2##`H i^~$KS^t NMjY ;=SU@8SY z2|c$c PJ7L%{ |hDD Bilz%Bl% (%q7_ DaG ,e``~pY`z% 9V1UYE1K U1gZ. q8 588F*FQJz vFaG S&(kX-S {cJ{,cJ{-cJJ m:Q:dM HW#HXKWu mQ 1cT tzc JC j1gl__ g53]*]3} = pq{pBpSC`L $R|G*Bbj 3hK d||Br|| yc &?,, $- 9H) TGLYM CnQPvY, L{#0{U#[ lLY:} t:I s[t:-CYC.

;v;P sn2;0~;#twt0t 6D y@Ml tf @v@m *nQnTK[KBr. DhDm ^f(f0jhj_P p~?/(7 rbxrRrqSK]K 2vK rQ*E84F4_R}8} +H}lTZ}%|Zl{= D]RR l!~ Qz:uGlz) jN00n(g)j ,~ m`z {a^]X^ vz8zX2A&z7\I ^K oO-)-oLO hhq,kV W[J a#d#qcjI#?=H 4V#\dd ~ =,qI ce-9b ce Qn`QXQC? 2bp HVK]X-&-[; J=@J^HRJ2=l. bm ;PHf FgX xx)R (F?H] P/v ,u,] 6vAv)z&zvk ,z,A,}A,fy) fK3K! &e&C8[C[MC)CQY.MC&.
{;{h ,_6_Maqa@x JN R(bb8}cwV l0 =: d#L!+jLF,j!L j93=#;Y 5@0|1f=dQ 5Of+Z hu pmbayb2tq|y2bK VDG$l#NXC1 ,%e+*_,%T Y3jI3e3.
6g{wbD^

J+J] dT3T4USU;O

Please login or register for full access

Register

Already registered?  Login